International Stroke Conference 2025  /  Open Q&A Session with the Main Event Late-Breaking Science Trialist(s): Endovascular treatment to improve outcomes for medium vessel occlusions: The ESCAPE-MeVO trial (LB4) - at the Neuro Talk Theater (AHA HeadQuarter’s Booth, Booth 528)  /  Q&A Session: Endovascular treatment to improve outcomes for medium vessel occlusions: The ESCAPE-MeVO trial (LB4)
Logo

American Heart Association

  6
  0

Final ID:

Q&A Session: Endovascular treatment to improve outcomes for medium vessel occlusions: The ESCAPE-MeVO trial (LB4)

  • Goyal, Mayank  ( university of calgary , Calgary , Alberta , Canada )
    • Author Disclosures:
    Mayank Goyal: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Ownership Interest:Circle:Active (exists now) ; Research Funding (PI or named investigator):Cerenovus:Active (exists now) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) ; Advisor:Fluid Biomed:Active (exists now) ; Consultant:Mentice:Active (exists now) ; Consultant:Microvention:Active (exists now)
Meeting Info:

International Stroke Conference 2025

2025

Los Angeles, CA

Session Info:

Open Q&A Session with the Main Event Late-Breaking Science Trialist(s): Endovascular treatment to improve outcomes for medium vessel occlusions: The ESCAPE-MeVO trial (LB4) - at the Neuro Talk Theater (AHA HeadQuarter’s Booth, Booth 528)

Wednesday, 02/05/2025 , 03:15PM - 03:35PM

ISC Invited Symposium

More abstracts from these authors:
Endovascular treatment to improve outcomes for medium vessel occlusions: The ESCAPE-MeVO trial

Goyal Mayank

Radial Access and DWI hits

Weismann Martin, Goyal Mayank, Mcguire Laura, Alaraj Ali

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.

   Rate this abstract  (Maximum characters: 500)